NHF Adds New Drugs for Arthritis and Major Depression to NHFCARD Programme
PRESS RELEASE - National Health Fund (NHF) cardholders are to benefit from the addition of new drugs for the treatment of Arthritis and Major Depression. Simponi Injection 50mg - 0.5mL with the active ingredient Golimumab with a subsidy of $105,896.05 per injection, Actemra Injection with active ingredient Tocilizumab with a subsidy of $27,568.00 per 200mg - 10mL injection and with...









